Mediwound Stock

Mediwound Debt 2024

Mediwound Debt

-35 USD

Ticker

MDWD

ISIN

IL0011316309

WKN

A110TG

In 2024, Mediwound's total debt was -35 USD, a 7.62% change from the -32.52 USD total debt recorded in the previous year.

Mediwound Aktienanalyse

What does Mediwound do?

Mediwound Ltd is an Israeli company specializing in the development and marketing of therapies for chronic and acute wounds. The company was founded in 2000 and is headquartered in Yavne, Israel. Its history began with the idea of developing an innovative treatment method for burns. The company collaborated closely with the Israeli Ministry of Defense to find a better method for wound treatment. The result was the product NexoBrid, an enzymatic debridement treatment that aims to remove dead tissue from burn wounds to enable faster healing. Mediwound's business model is to develop and market innovative drugs and therapy solutions for wounds. The company operates in several areas, including burn wounds, chronic wounds, and trauma wounds. In the burn wounds sector, Mediwound offers the product NexoBrid, which enzymatically removes dead tissue from burns and eliminates neurotoxic substances that can damage wound healing if left in the tissue for too long. NexoBrid is already approved in several countries, including the USA and European countries. In the chronic wounds sector, Mediwound offers the product EscharEx, which is used to treat chronic wounds such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers. EscharEx also uses an enzymatic approach and aims to remove dead tissue to enable the body's natural healing process. There are plans to launch EscharEx in Europe in the second half of 2021. Mediwound also operates in the trauma wounds sector and received the product MWPC003 in Europe in 2020. It is a novel enzymatic debriding product that can be used in the integrated therapy of complex trauma wounds with additional topical treatment options. Through the development of innovative therapies and drugs, Mediwound has established itself as a reliable partner in wound treatment. The company continues to focus on innovation and plans to expand its product range in the future. Overall, Mediwound Ltd is a groundbreaking company in the field of wound care. The company's products and solutions contribute to faster and more effective wound healing, improving the lives of patients worldwide. Mediwound ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Mediwound's Debt Structure

Mediwound's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Mediwound's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Mediwound’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Mediwound’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Mediwound stock

What is the debt of Mediwound this year?

Mediwound has a debt level of -35 USD this year.

What was the debt of Mediwound compared to the previous year?

The debt of Mediwound has increased by 7.62% compared to the previous year increased.

What are the consequences of high debt for investors in Mediwound?

High debt can pose a risk for investors of Mediwound, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Mediwound?

Low debt means that Mediwound has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Mediwound affect the company?

An increase in debt of Mediwound can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Mediwound affect the company?

A reduction in debt of Mediwound can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Mediwound?

Some factors that can influence the debt of Mediwound include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Mediwound so important for investors?

The debts of Mediwound are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Mediwound take to change the debt?

To change the debt, Mediwound can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Mediwound pay?

Over the past 12 months, Mediwound paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Mediwound is expected to pay a dividend of 0 USD.

What is the dividend yield of Mediwound?

The current dividend yield of Mediwound is .

When does Mediwound pay dividends?

Mediwound pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Mediwound?

Mediwound paid dividends every year for the past 0 years.

What is the dividend of Mediwound?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Mediwound located?

Mediwound is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mediwound kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mediwound from 11/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/6/2024.

When did Mediwound pay the last dividend?

The last dividend was paid out on 11/6/2024.

What was the dividend of Mediwound in the year 2023?

In the year 2023, Mediwound distributed 0 USD as dividends.

In which currency does Mediwound pay out the dividend?

The dividends of Mediwound are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Mediwound

Our stock analysis for Mediwound Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mediwound Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.